The future of
single-domain antibodies



Meet us at the NYAS-Antibody-Drug Conjugates meeting

New-York, NY, USA - 14 November

Antibody-Drug conjugates or ADCs combine the unique targeting properties of monoclonal antibodies with the potent cell killing ability of cytotoxic drugs. Unlike traditional chemotherapeutic agents, ACDs allow a sensitive targeting of cancer cells while avoiding healthy cells and represent a promising lead for cancer treatments.

On November 14th, the New York Academy of Sciences organizes a symposium in New-York, entitled "Antibody-Drug Conjugates: Oncology and Beyond", to discuss the challenges and last discoveries around this innovative therapeutic approach.

Dr. Petra Tafelmeyer, Director of Scientific Project USA, will attend this event and will be happy to discuss with you how your project can benefit from our services. Feel free to contact us now to arrange a meeting with her.

 

NYAS-Antibody-Drug Conjugates: Oncology and Beyond

Add to Calendar 11-14-2017 00:00:00 11-14-2017 00:00:00 35 NYAS-Antibody-Drug Conjugates: Oncology and Beyond Meet Petra in NY for a NYAS meeting around ADCs New-York, NY, USA NYAS true MM/DD/YYYY

 

Back to news

Back to Top